EGFR and lung carcinoma: NAC was previously found to restore the sensitivity of gefitinib-resistant lung cancer cells to gefitinib that is a major epithelial growth factor receptor tyrosine kinase inhibitor, suggesting the inhibitory effects of NAC on EGFR activation in epithelial cells [24].